EFCAB4B Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

EFCAB4B Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 14 amino acids near the carboxy terminus of human EFCAB4B.

  Source: Synthetic

  (Accession #: NP_116069)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: CRACR2A
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76493.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for EFCAB4B Antibody Blocking Peptide

• Calcium release-activated calcium channel regulator 2A
• CRAC channel regulator 2A
• CRACR2A
• DKFZp686G13246
• EF-hand calcium binding domain 4B
• EF-hand calcium-binding domain-containing protein 4B
• FLJ33046
• FLJ33805
• MGC4266

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: CRACR2A